Extended release formulation of nevirapine

Details for Australian Patent Application No. 2008262031 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Cappola, Michael L.; Sienkiewicz, Svetlana; Snow, Glenn Charles; Chen, Feng-Jing

Agent Davies Collison Cave

Pub. Number AU-B-2008262031

PCT Pub. Number WO2008/154234

Priority 60/942,765 08.06.07 US

Filing date 4 June 2008

Wipo publication date 18 December 2008

Acceptance publication date 25 August 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/154234 Priority application(s): WO2008/154234

25 August 2011 Application Accepted

  Published as AU-B-2008262031

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262038-5-heteroaryl substituted indazoles as kinase inhibitors

2008262019-Medical device and method to correct deformity